Free Trial

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Short Interest Up 6.3% in November

Aveanna Healthcare logo with Medical background

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) was the recipient of a significant growth in short interest during the month of November. As of November 30th, there was short interest totalling 1,180,000 shares, a growth of 6.3% from the November 15th total of 1,110,000 shares. Based on an average daily volume of 311,600 shares, the short-interest ratio is presently 3.8 days. Currently, 2.1% of the company's stock are sold short.

Institutional Investors Weigh In On Aveanna Healthcare

Large investors have recently added to or reduced their stakes in the business. Intech Investment Management LLC bought a new position in shares of Aveanna Healthcare in the third quarter valued at about $69,000. XTX Topco Ltd bought a new position in Aveanna Healthcare in the 3rd quarter valued at about $92,000. Virtu Financial LLC acquired a new stake in Aveanna Healthcare during the third quarter worth approximately $99,000. SG Americas Securities LLC bought a new stake in shares of Aveanna Healthcare during the third quarter worth approximately $101,000. Finally, Mackenzie Financial Corp grew its position in shares of Aveanna Healthcare by 35.9% in the second quarter. Mackenzie Financial Corp now owns 45,674 shares of the company's stock valued at $126,000 after purchasing an additional 12,075 shares during the last quarter. Institutional investors own 87.96% of the company's stock.

Aveanna Healthcare Trading Down 0.8 %

Shares of NASDAQ:AVAH traded down $0.04 during trading on Friday, hitting $5.03. 133,740 shares of the company were exchanged, compared to its average volume of 200,241. Aveanna Healthcare has a fifty-two week low of $2.00 and a fifty-two week high of $6.19. The firm has a fifty day moving average price of $5.28 and a two-hundred day moving average price of $4.48. The stock has a market cap of $971.92 million, a price-to-earnings ratio of -14.79 and a beta of 2.20.

Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) last posted its quarterly earnings results on Thursday, November 7th. The company reported $0.02 EPS for the quarter, topping analysts' consensus estimates of ($0.01) by $0.03. The business had revenue of $509.02 million for the quarter, compared to the consensus estimate of $495.80 million. During the same quarter in the previous year, the business posted ($0.05) EPS. As a group, research analysts predict that Aveanna Healthcare will post -0.08 EPS for the current year.

About Aveanna Healthcare

(Get Free Report)

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.

Featured Articles

Should you invest $1,000 in Aveanna Healthcare right now?

Before you consider Aveanna Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aveanna Healthcare wasn't on the list.

While Aveanna Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Broadcom Hits $1 Trillion – Can This AI Powerhouse Go Higher?
SoundHound Stock Explodes Again – Is a Major Breakout Coming?
How Fintech Strategy at FinWise Bancorp and CEO Vision Are Driving 78% Gains

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines